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Edited by Jesus AvilaAbstract Abnormally nitrated tau has been found recently in
the neuroﬁbrillary tangles of Alzheimers disease (AD). How-
ever, whether and how nitration of tau is involved in AD pathol-
ogy is not known. Herein, we found that in vitro incubation of
peroxynitrite with recombinant tau resulted in nitration and olig-
omerization of tau in a dosage-dependent manner. Moreover, the
nitrated tau showed a signiﬁcantly decreased binding activity to
taxol-stabilized microtubulesin in vitro. Further study demon-
strated that peroxynitrite also induced tau nitration in neuroblas-
toma N2a cell line, and the nitrated tau was accumulated in the
cells. We conclude that abnormal nitration of tau contributes to
the impaired biological activity of tau in binding to the microtu-
bules and the aggregation of tau, implying a novel mechanism
responsible for the neurodegeneration seen in AD brain.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Neuroﬁbrillary tangle (NFT) and b-amyloid (Ab) plaques
are the two deﬁning features of Alzheimers disease (AD).
NFT are composed of bundles of paired helical ﬁlament
(PHF), whose major protein subunit is abnormally hyperphos-
phorylated microtubule-associated protein tau [1–3]. By bind-
ing to microtubule, tau functions to promote tubulin
polymerization and maintains microtubule stability [4,5].
When tau is abnormally hyperphosphorylated both in vitro
and in vivo, its binding aﬃnity for microtubule is decreased,
thus leading to the disruption of the neuronal cytoskeleton
[6–8]. In addition, several tau gene mutations have been iden-
tiﬁed in frontotemporal dementia and Parkinsonism linked to
chromosome 17 (FTDP-17), providing further genetic evidence
for tau dysfunction in neurodegeneration [9–11]. All these
studies prove that tau abnormalities impair its functions and
thus play important role in pathogenesis of neurodegenerative
disease.
Studies demonstrated that there existed widely nitrative le-
sions in AD brain. The levels of 3-nitrotyrosine and dityrosine,*Corresponding author. Fax: +86 27 83693883.
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in the hippocampus, neocortical regions and cerebrospinal
ﬂuid (CSF) of AD patients [12]. Moreover, both the 3-nitroty-
rosine concentration and the 3-nitrotyrosine/tyrosine ratio in
the CSF increased signiﬁcantly and this elevation correlates
positively with decreased cognitive functions [13]. While the in-
creased protein nitration was found in neurons, including but
certainly not restricted to those containing NFT [14]. Proteo-
mic identiﬁcation of nitrated proteins in AD brain has detected
six target proteins including enolase and triosephosphate isom-
erase, both of which are important enzymes in glucose metab-
olism and nitration may decrease their activities that may
account for the metabolic impairment in AD [15]. Recently,
it was reported that tau was nitrated and co-localized with
NFT in AD brain [16]. However, how nitrated tau may con-
tribute to AD pathology is not understood.
Peroxynitrite, the product of the rapid reaction between
superoxide anions (O2) and nitric oxide (NO), is a potent
nitration mediator and strong oxidant implicated in AD
[12,14,17]. At physiological pH, peroxynitrite becomes perox-
ynitrous acid, a species that rapidly undergoes hemolytic cleav-
age to yield OH and NO2 that ﬁrstly oxidize tyrosine to form
tyrosyl radical (Tyr). Then, NO2nitrates Tyr to form 3-
nitrotyrosine and Tyr also interacts with each other to gener-
ate dityrosine [18,19]. It has been manifested that peroxynitrite
may nitrate various proteins both in vitro and in vivo [20–27].
In the present study, we demonstrated that peroxynitrite
treatment causes tau nitration and oligemerizion; such abnor-
mal modiﬁcations inhibit microtubule-binding activity of tau.
We propose that tau nitration may contribute to AD patho-
genesis through impairing normal functions of tau.2. Materials and methods
2.1. Materials
Dithiothreitol (DTT), iodoacetamide, GTP, paclitaxel and Hoechst
33258 were purchased from Sigma (St. Louis, MO, USA). P11 cellu-
lose phosphate was from Whatman Inc. (Clifton, NJ, USA), seph-
acryl S-300 was from Pharmacia Biotech (Uppsala, Sweden).
Peroxynitrite and 3-nitrotyrosine monoclonal antibody were pur-
chased from Cayman Chemical Co. (Ann Arbor, MI, USA). Anti-tau
monoclonal antibody tau5 was purchased from Lab Vision Corpora-
tion (Fermont, CA, USA). Anti-a-tubulin mAb DMIA and rabbit
polyclonal antibody R134d against total tau were gifts from Dr. K Iq-
bal and I Grundke-Iqbal (New York State Institute for Basic Re-
search, Staten Island, NY, USA). Anti-nitrated tau monoclonal
antibody n847 was a gift from Dr. John Q. Trojanowski (Center for
Neurodegenerative Disease Research, Department of Pathology
and Laboratory Medicine, Hospital of The University of Pennsylva-
nia, Philadelphia, PA, USA). Rhodamine Red-X-conjugated goatblished by Elsevier B.V. All rights reserved.
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mouse IgG (H + L) were from Molecular Probes (Eugene, OR, USA).
Goat anti-rabbit and anti-mouse peroxidase-conjugated secondary
antibody, chemiluminescent substrate kit were from Pierce Chemical
Company (Rockford, IL, USA).
2.2. Puriﬁcation of tau
Human 3R tau (htau39) that has three tandem C-terminal repeats
plus two 58-amino acid N-terminal inserts was expressed in Escherichia
coli strain BL21 and tau was isolated from the bacterial lysate as de-
scribed [28,29]. Brieﬂy, the bacterial pellet was lysed in homogenate
buﬀer (50 mMMes, 5 mM DTT, and 5 mM PMSF, pH 6.8), then cen-
trifuged at 4 C, 38000 · g for 30 min to collect supernatant. After
adding equal volume solution containing 1 mM MgCl2 and 0.2 mM
EDTA, the supernatant was loaded onto a phosphocellulose column.
The column was washed thoroughly and proteins were eluted with gra-
dient 0–0.5 M NaCl in PC buﬀer (25 mM Mes, 1 mM DTT, 0.5 mM
MgCl2, and 0.1 mM EDTA, pH 6.8). The positive fractions identiﬁed
by dot blot were bath in boiled water for 10 min. After centrifuging at
4 C, 48000 · g for 30 min, the supernatant containing tau was concen-
trated by ultraﬁltration and loaded onto Sephacryl S-300 Gel ﬁltration
column prewashed with PC buﬀer. The collected fractions were ana-
lyzed by Western blot and then puriﬁed tau fractions were desalted
and concentrated by ultraﬁltration for further study.
2.3. Treatment of tau with peroxynitrite
The reaction of peroxynitrite with tau was carried out as described
previously [20] with minor modiﬁcations. Brieﬂy, tau (1 mg/ml) dis-
solved in reaction buﬀer (100 mM potassium phosphate, 25 mM so-
dium bicarbonate, and 0.1 mM diethylenetriamine pentaacetic acid,
pH 6.4) was reacted with or without peroxynitrite at 37 C for
10 min. The concentration of peroxynitrite stock solution was deter-
mined by measuring the absorbance at 302 nm (e302 = 1670 M
1
cm1) and the ﬁnal concentration peroxynitrite used in the reaction
was 0.025, 0.125, 0.25 0.625 and 1.25 mM, respectively. At the end
of incubation, the complete decomposition of peroxynitrite was deter-
mined by the above method. DTT and iodoacetamide are agents pre-
vented formation of disulﬁde bond. After addition of 10 mM DTT in
reaction buﬀer, tau was treated with peroxynitrite as indicated concen-
trations. Iodoacetamide (15 mM) ﬁrstly alkylated sulfhydryls of cys-
teine residue of tau in reaction buﬀer at 37 C for 30 min, and then
tau was reacted with diﬀerent concentrations of peroxynitrite as de-
scribed above. The reaction was terminated by addition of one-third
volume of sample buﬀer containing 200 mM Tris–HCl, pH 7.6, 8%
SDS, 40% glycerol, 40 mM DTT, 0.025% bromophenol blue and
boiled for 10 min. The equal amounts of protein were used for Western
blot analysis.2.4. Puriﬁcation of porcine tubulin
Tubulin was isolated from porcine brain by two temperature-
dependent polymerization–depolymerization cycles as described [30],
followed by the removal of the microtubule-associated proteins
(MAPs) through phosphocellulose chromatography in PM buﬀer
(100 mM Pipes, pH 6.9, 2 mM EGTA, 1 mM MgSO4, and 2 mM
DTT). Aliquots were drop-frozen in liquid nitrogen and stored at
80 C. Protein concentrations were determined by Bradford method
[31].2.5. Microtubule-binding assay
Taxol-stabilized microtubules were prepared as described [32].
Brieﬂy, MAPs-free tubulin (2 mg/ml) was incubated with 1 mM
MgSO4, 1 mM GTP and 5% DMSO at 37 C for 45 min. Then taxol
was added to the mixture at a ﬁnal concentration of 60 lM for further
10 min incubation at 37 C. The microtubules in pellets were collected
by centrifugation at 22 C, 96000 · g for 20 min. The binding ability of
tau to microtubules was determined as described [6]. Brieﬂy, tau
(50 lg/ml) or peroxynitrite-treated tau (50 lg/ml) was incubated with
taxol-stabilized microtubules (0.5 mg/ml) at 37 C for 30 min in a buf-
fer containing 80 mM Pipes (pH 6.9), 1 mM EGTA, 1 mMMgSO4 and
1 mMGTP. Bound tau in pellets and unbound tau in supernatants was
separated by centrifugation at 22 C, 50000 · g for 20 min. Both super-
natant and pellet were recovered for Western blot analysis with anti-
tau monoclonal antibody tau5.2.6. Western blot
The equal amounts of protein were separated by a 10% SDS–poly-
acrylamide gel, and then transferred on to nitrocellulose membranes.
Membranes were blocked with 5% defatted milk dissolved in TBS–
Tween (TBS–T) (50 mM Tris, pH 7.6, 150 mM NaCl, and 0.2% Tween
20) for 1 h at 37 C. The blot was then incubated with anti-tau mono-
clonal antibody tau5 (1:2000) or 3-nitrotyrosine monoclonal antibody
(1:500) or anti-a-tubulin mAb DMIA (1:500) or mAb n847 (1:500)
overnight at 4 C. The membrane was washed three times with TBS-
T and then incubated with anti-mouse IgG conjugated to horse radish
peroxidase (1:3000) for 1 h at 37 C. The blot was washed three times
with TBS-T and then visualized using enhanced chemiluminescence
method. The protein bands were quantitatively analyzed by Kodak
Digital Science 1D software (Eastman Kodak Company, New Haven,
CT, USA), and the amount of protein was expressed as sum optical
density.
2.7. Cell culture, protein extraction and immunoﬂuorescence staining
N2a/Peuht39 cells, a Neuroblastoma N2awt cell line (a kind gift
from Dr. HX Xu, The Burnham Institute, San Diego, USA) stably
transfected with the human tau cDNA (Tau39), were grown in 6-well
or 24-well plates in DMEM: OPTI-MEM (1:1) in the presence of
200 lg/ml G418 with 5% FBS (vol/vol) in a humidiﬁed atmosphere
of 5% CO2, at 37 C. Cells in 70% of conﬂuence were treated with
0.02, 0.05, 0.1, 0.25 or 0.5 mM of peroxynitrite. As obvious nitration
of tau was only observed by 0.5 mM of peroxynitrite, we used this con-
centration for the cell studies. After 24 h of peroxynitrite treatment,
cells were lysed for protein extraction with buﬀer containing 50 mM
Tris–Cl, pH 8.0, 150 mM sodium chloride, 1% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS, 0.02% sodium azide, 100 lg/ml PMSF, and
10 lg/ml protease inhibitors (leupeptin, aprotinin, and pepstatin) fol-
lowed by probe sonicate for 5 s on ice. The cell lysates were then cen-
trifuged at 12000 · g for 10 min at 4 C; aliquots of supernatants were
added to one-third volume of sample buﬀer, boiled for 10 min, and
then used for Western blot analysis. For immunoﬂuorescence staining,
cells were ﬁxed with methanol at 20 C for 5 min and permeabilized
with PBS-0.5% Triton X-100 for 5 min. After blocking with 5% BSA
for 1 h at 37 C, the cultures were incubated overnight at 4 C with
mAb n847 (1:500) which specially recognized nitrated tau [16] or with
rabbit polyclonal anti-tau R134d (1:1500). After washing, cells were
incubated with the secondary antibody (Rhodamine Red-X-conju-
gated goat anti-rabbit IgG (1:2000) for R134d, Oregon Green 488-con-
jugated goat anti-mouse IgG (1:2000) for n847) at 37 C for 1 h.
Finally, Hoechst 33258 (1 lg/ml) was used to stain the nuclei. Fluores-
cence was observed using a ﬂuorescence microscope (BX60; Olympus,
Tokyo, Japan) with appropriate ﬁlter sets.
2.8. Statistical analysis
Data were expressed as means ± S.E. and analyzed using SPSS 11.5
statistical software (SPSS Inc., Chicago, IL, USA).3. Results
3.1. Peroxynitrite induces tau nitration and oligomerization
Puriﬁed human recombinant tau was treated with diﬀerent
concentrations of peroxynitrite in the presence of CO2 in vi-
tro and the products were analyzed by Western blot with 3-
nitrotyrosine mAb (Fig. 1A and D) or mAb tau-5 to tau
(Fig. 1B and C). We observed that exposure of tau to perox-
ynitrite/CO2 led to tau nitration and oligomerization in a dos-
age-dependent manner (Fig. 1A and B). Although nitrated
tau was mainly monomers, distinct nitrated tau dimers, trim-
mers and oligomers were also detected (Fig. 1A), and the de-
crease of tau monomer was consistent to the increase of tau
oligomers upon peroxynitrite treatment (Fig. 1B). We also
observed that tau nitration and oligomerization were com-
pletely abolished by addition of 10 mM DTT to the reaction
buﬀer (Fig. 1A and B), however, peroxynitrite-induced nitra-
tion and oligomerization of tau was still seen when iodoacet-
Fig. 1. Peroxynitrite treatment induces nitration and oligomerization of tau in vitro. Puriﬁed human recombinant tau was treated with diﬀerent
concentrations (0.025, 0.125, 0.250, 0.625, 1.25 mM) of peroxynitrite (A and B, lanes 2–6), with DTT (A and B, lanes 7–12) or iodoacetamide (C and
D, lanes 2–7). Untreated tau served as control. After reaction, the protein was separated by 10% SDS–PAGE, followed by electrophoretic transfer to
nitrocellulose membranes and Western blot analysis with an anti-tau monoclonal antibody tau5 (B and C) or an anti-3-nitrotyrosine antibody (A and
D). The blots are representatives of three independent experiments.
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tion of disulﬁde bond (Fig. 1C and D). These data demon-
strate that peroxynitrite induces eﬃciently tau nitration and
oligomerization in vitro. And it is also suggested that for-
mation of disulﬁde bond may only play minor role in tau
oligomerization.
3.2. Peroxynitrite inhibits the binding of tau to microtubules
To investigate the eﬀect of tau nitration and oligomerization
on its biological activity, we measured the in vitro microtu-
bule-binding activity of tau by using taxol-stabilized microtu-
bules. We found that microtubule-bound tau monomer in
the pellet (Fig. 2A) was decreased whereas unbound tau mono-
mer in the supernatant (Fig. 2B) was increased dose-depen-
dently after peroxynitrite treatment. Although tau oligomers
were seen in both microtubule-bound and -unbound fractions,
the amount of microtubule-bound tau oligomers was much less
than that of unbound tau oligomers (Fig. 2A and B), and tauoligomers by themselves did not precipitate at the condition
used (data not shown). Quantitative data showed that the ratio
of microtubule-bound to unbound tau was decreased 36%,
58% and 64% of the normal control level after treatment of
peroxynitrite at concentrations of 0.125, 0.625 and 1.25 mM,
respectively (Fig. 2C). These data suggest that nitration and
oligomerization of tau induced by peroxynitrite inhibits its
microtubule-binding activity.3.3. Peroxynitrite induces tau nitration and aggregation in
N2a/Peuht39 cells
To study whether peroxynitrite could also nitrate tau in the
cell, we treated N2a/Peuht39 cell line with 0.5 mMperoxynitrite
for 24 h and nitration of tau in the cell was measured by mAb
n847, an antibody speciﬁcally reacts with nitrated tau. Immuno-
blotting results conﬁrmed the presence of nitrated tau mono-
mer and oligomers in lysates of N2a/Peuht39 cells treated with
Fig. 2. Peroxynitrite treatment inhibits microtubule-binding ability of
tau. Puriﬁed human recombinant tau was treated with various
concentrations (0.125, 0.625 and 1.25 mM) of peroxynitrite (lanes 2–
4), and incubated with taxol-stabilized microtubules. Untreated tau
served as control. Microtubule-bound tau in the pellets (A) and
unbounded tau in supernatants (B) was separated by centrifugation
and subjected to Western blot analysis with an anti-tau monoclonal
antibody tau5. The ratio of bound tau to unbound tau in each sample
was calculated and statistic analysis showed that the ratio signiﬁcantly
declined for peroxynitrite-treated tau (C). Micrographs represented
results of three independent experiments (means ± S.E.). *P < 0.05,
**P < 0.01.
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also observed that treatment of the cells with peroxynitrite led to
retraction of cell processes and accumulation of total tau probed
by R134d (Fig. 3Bh). The nitration of tau was only seen in
peroxynitrite-treated (Fig. 3Bd) but not in control cells, and
moreover, nitrated tau was aggregated in the cells (Fig. 3Bd),
which were correlated positively with the accumulation of tau
(see Fig. 3Bh). Hoechst 33258 was used to stain the nuclei as a
reference of cell integration (Fig. 3Bc and Bg). These data
suggest that peroxynitrite not only induces nitration but also
accumulation of tau in N2a/Peuht39 cell line.4. Discussion
Abnormal posttranslational modiﬁcations including hyper-
phosphorylation, glycosylation, glycation, ubiquitination and
truncation of microtubule-associated protein tau have been
previously reported to play diﬀerent roles in the development
of AD pathology [33], such as hyperphosphorylation but not
glycosylation of tau inhibits its biological activity in promoting
microtubule assembly and in stabilizing the already formedmicrotubules, whereas glycosylation of tau stabilizes the struc-
ture of neuroﬁbrillary tangles [34]. In addition to these post-
translational modiﬁcations, it is found recently that tau
isolated from paired helical ﬁlament in AD brains is nitrated
and the extent of nitration is well correlated with the evolution
of the disease [16]. However, the nature of tau nitration in AD
pathology is not known.
In the present study, we have demonstrated that peroxyni-
trite induces both nitration and oligomerization of tau in vi-
tro. The extent of nitration and formation of oligomers were
concentration dependent. Since the oligomers were resistant
to denaturation by SDS and boiling (conditions used to han-
dle the samples for electrophoresis), the covalent bonds must
be involved. To this point, it was reported previously that
peroxynitrite resulted in formation of dityrosine bond in a-
synuclein [22]. Additionally, peroxynitrite could also oxidize
–SH group in cysteine residue of tau to form disulﬁde bond
[35]. As human tau39 (htau39) we used in the present study
contains only one cystine (i.e., Cys-291), the disulﬁde bond
formed from this cystine should only lead to formation of
tau dimmers rather than oligomers. To verify the role of dity-
rosine bond in stabilizing tau oligomers, we treated tau with
iodoacetamide, an alkylating agent that blocks formation of
disulﬁdes, prior to addition of peroxynitrite. We found that
tau was still oligomerized at this condition (Fig. 1C), suggest-
ing the major role of dityrosine bond in stabilizing nitrated
tau in the present study. Supporting results was reported in
a-synuclein, a neuronal protein shown similar biological
and biophysical properties to tau both in normal and patho-
logic states [36].
We also found that addition of disulﬁde reducing agent
DTT into the reaction system not only completely abol-
ished the oligomerization of tau, but also completely inhib-
ited tau nitration. DTT is a strong reducing agent. One of
the possible reasons for the prevention of nitration of tau
by DTT may be due to the inactivation of the peroxynitrite
by reduction.
Studies have demonstrated that tyrosine nitration of pro-
teins alters theirs biophysical properties and biological
activities [22,24,37–39]. Thus, we tested whether the microtu-
bule-binding activity of tau was aﬀected by peroxynitrite
treatment in vitro. The results showed that the microtu-
bule-binding activity of nitrated and oligomerized tau was
signiﬁcantly inhibited compared with that of normal tau.
The majority of them were dissociated from microtubules
after peroxynitrite treatment. The extent of inhibition was
correlated with increased nitration and oligomerization of
tau. These results suggest that nitration and oligomerization
of tau inhibits its microtubule-binding activity or that ni-
trated tau may sequester normal tau, implying the role of
tau nitration in disruption of microtubule system as seen
in AD pathology.
There are ﬁve tyrosine (Y) residues in amino acid sequence
of htau39, i.e., Y18, Y29, Y197, Y279 and Y363. Among them
Y279 is located in microtubule-binding domain. Thus, it is rea-
sonable to speculate that nitration of Y279 may play major
role in the inhibition of microtubule-binding activity. How-
ever, site-speciﬁc mutation of the above ﬁve tyrosine is needed
to conﬁrm the speculation.
We further investigated the role of tau nitration in N2a/
Peuht39 cells. We found that in untreated control cells, tau dis-
tributed throughout the neuritis and the cytoplasm. But in per-
Fig. 3. Peroxynitrite induces tau nitration and aggregation in N2a/Peuht39 cells. N2a/Peuht39 cells were treated with 0.5 mM peroxynitrite and
analyzed after 24 h. (A) Cell lysates were subjected to Western blot analysis with mAb n847 which specially recognized nitrated tau. (B) Control (a, b,
e, f) or treated cells (c, d, g, h) were studied by immunoﬂuorescence staining with mAb n847 (b, d) or rabbit polyclonal antibody R134d to total tau (f,
h) and the nuclei of the cells were counterstained by Hoechst 33258 (a, c, e, g). Arrowheads indicated distribution of nitrated tau (d) or total tau (f, h).
Scale bar = 10 lm.
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and the cells appeared round and the neurite were retracted.
These results imply that nitration of tau may disrupt cytoskel-eton of the cells. The relationship of tau nitration with other
posttranslational modiﬁcations, such as hyperphosphoryla-
tion, needs further investigation.
2426 Y.J. Zhang et al. / FEBS Letters 579 (2005) 2421–2427Taken together, we have found in the present study that tau
can be nitrated and oligomerized by peroxynitrite. Nitration of
tau impairs its microtubule-binding activity and accumulates
in neuroblastoma N2a cells.
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